Fresenius SE & Co. KGaA

XTRA:FRE Stock Report

Market Cap: €24.3b

Fresenius SE KGaA Balance Sheet Health

Financial Health criteria checks 4/6

Fresenius SE KGaA has a total shareholder equity of €20.1B and total debt of €12.2B, which brings its debt-to-equity ratio to 60.5%. Its total assets and total liabilities are €43.2B and €23.1B respectively. Fresenius SE KGaA's EBIT is €1.9B making its interest coverage ratio 4.7. It has cash and short-term investments of €2.4B.

Key information

60.54%

Debt to equity ratio

€12.15b

Debt

Interest coverage ratio4.7x
Cash€2.39b
Equity€20.07b
Total liabilities€23.14b
Total assets€43.21b

Recent financial health updates

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Mar 31
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Dec 20
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jul 15
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Recent updates

This Is Why Fresenius SE & Co. KGaA's (ETR:FRE) CEO Compensation Looks Appropriate

May 17
This Is Why Fresenius SE & Co. KGaA's (ETR:FRE) CEO Compensation Looks Appropriate

These Return Metrics Don't Make Fresenius SE KGaA (ETR:FRE) Look Too Strong

Apr 15
These Return Metrics Don't Make Fresenius SE KGaA (ETR:FRE) Look Too Strong

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Mar 31
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Why We're Not Concerned About Fresenius SE & Co. KGaA's (ETR:FRE) Share Price

Mar 15
Why We're Not Concerned About Fresenius SE & Co. KGaA's (ETR:FRE) Share Price

Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Jan 10
Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Dec 20
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Getting In Cheap On Fresenius SE & Co. KGaA (ETR:FRE) Might Be Difficult

Nov 29
Getting In Cheap On Fresenius SE & Co. KGaA (ETR:FRE) Might Be Difficult
author-image

Biopharma Innovations And Critical Growth Initiatives Propel Earnings And Margin Expansion

Strategic initiatives focused on productivity and organic growth are expected to enhance operational efficiency and drive margin expansion.

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jul 15
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Jun 12
Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

May 28
At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Financial Position Analysis

Short Term Liabilities: FRE's short term assets (€11.9B) exceed its short term liabilities (€8.3B).

Long Term Liabilities: FRE's short term assets (€11.9B) do not cover its long term liabilities (€14.8B).

Debt to Equity History and Analysis

Debt Level: FRE's net debt to equity ratio (48.6%) is considered high.

Reducing Debt: FRE's debt to equity ratio has reduced from 81.7% to 60.5% over the past 5 years.

Debt Coverage: FRE's debt is well covered by operating cash flow (20.6%).

Interest Coverage: FRE's interest payments on its debt are well covered by EBIT (4.7x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 21:46
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fresenius SE & Co. KGaA is covered by 48 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Robert BateBarclays
Hassan Al-WakeelBarclays